Lockheed Martin Investment Management’s DexCom DXCM Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2018
Q2
Sell
-31,120
Closed -$577K 98
2018
Q1
$577K Hold
31,120
0.02% 110
2017
Q4
$446K Sell
31,120
-480
-2% -$6.24K 0.02% 120
2017
Q3
$387K Sell
31,600
-38,000
-55% -$672K 0.02% 128
2017
Q2
$1.27M Buy
+69,600
New +$1.29M 0.07% 104
2016
Q4
Sell
-88,000
Closed -$1.93M 115
2016
Q3
$1.93M Sell
88,000
-88,000
-50% -$1.96M 0.17% 76
2016
Q2
$3.49M Buy
+176,000
New +$3M 0.35% 44
2015
Q1
Sell
-50,000
Closed -$688K 133
2014
Q4
$688K Hold
50,000
0.03% 101
2014
Q3
$500K Hold
50,000
0.02% 102
2014
Q2
$496K Buy
+50,000
New +$443K 0.02% 117

Other funds holding DXCM

Lockheed Martin Investment Management's DXCM Position: Q2 2018 in Review

Lockheed Martin Investment Management sold out of DexCom (DXCM) in Q2 2018, closing a stake of 31,120 shares — an estimated $577K sold.

Lockheed Martin Investment Management first reported a position in DXCM in Q2 2014 and held it in 9 quarters. The position peaked at $3.49M in Q2 2016. 290 funds tracked by Wall St. Rank hold DXCM as of Q2 2018.

  • Lockheed Martin Investment Management reported no remaining DexCom position as of Q2 2018 after selling out during the quarter.
  • Lockheed Martin Investment Management sold 31,120 DexCom shares in Q2 2018, an estimated $577K.
  • Lockheed Martin Investment Management first reported a position in DexCom in Q2 2014 and held it in 9 quarters.
  • Lockheed Martin Investment Management's DexCom position peaked at $3.49M in Q2 2016.
  • 290 funds tracked by Wall St. Rank held DexCom as of Q2 2018.

Based on Lockheed Martin Investment Management's 13F filing for Q2 2018, filed 14 Aug 2018.